Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound (DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region - Global Forecasts to 2027
Updated on : March 21, 2023
The global wound care market in terms of revenue was estimated to be worth $20.8 billion in 2022 and is poised to reach $27.2 billion by 2027, growing at a CAGR of 5.4% from 2022 to 2027.
Added COVID-19: Impact analysis on the wound care market in the research methodology, products, wound type, end users, and region-wise impact in the regional chapter. The new edition of the report provides the market size and forecast for each of the regions along with their respective countries. In this edition of the report, the market in Europe has been divided into Germany, the UK, France, Italy, Spain, Russia, and the Rest of Europe. Similarly, the market in Asia Pacific has been divided into Japan, China, India, Australia, South Korea, Singapore, and the Rest of Asia Pacific. The market size and forecast for Latin America (Brazil, Mexico, and the Rest of Latam), the Middle East, and Africa have also been provided. We have added market shares for the top players. Recent developments can help you understand market trends and growth strategies used by market participants. The report provides updated developments in product launches and approvals, partnerships, acquisitions, collaborations, agreements, expansion, contracts, and other developments. Increasing expenses on wound and patient care, increased focus on developing products for wound management, and public awareness of wound care drive the growth of this market.
To know about the assumptions considered for the study, Request for Free Sample Report
Wound Care Market Dynamics
Drivers: rising incidence of diabetes that affects wound healing
The rising incidence of diabetes is driving growth in the wound care market. Diabetes can cause a range of complications, including poor circulation, decreased immune system function, and impaired wound healing. As the number of people with diabetes rises, so too does the demand for wound care products and services. This demand is driving growth in the wound care market. Wound care products such as dressings, wound cleansers, and wound closure products are used to help treat diabetic wounds and reduce the risk of infection. Additionally, healthcare providers are increasingly turning to advanced wound care technologies such as negative pressure wound therapy, hyperbaric oxygen therapy, and tissue engineering to help accelerate the healing process.
Opportunities: Emerging Countries
The wound care market is expected to witness significant growth in emerging countries, primarily due to increasing prevalence of chronic diseases, rising geriatric population, and growing awareness about wound care management. Moreover, increasing healthcare expenditure and initiatives by governments to increase the availability of wound care products are also expected to boost market growth.
In emerging countries, the demand for advanced wound care products is growing rapidly due to increasing awareness about wound care management, rising geriatric population, and increasing prevalence of chronic conditions. Moreover, governments in these countries are taking initiatives to increase the availability of wound care products. For instance, the Indian government has launched the Pradhan Mantri Jan Aushadhi Yojana to provide affordable generic drugs to the population. This initiative has made wound care products more accessible and affordable, which is expected to drive the market growth in India.
In addition, the increasing number of surgical procedures in emerging countries, such as Brazil and China, is also driving the market growth. According to the World Health Organization, the number of surgical procedures in China increased from 106 million in 2009 to 233 million in 2015, with an annual growth rate of 11.7%. This trend is expected to continue in the coming years, which will increase the demand for wound care products in the country. Furthermore, the rising investments in healthcare infrastructure in these countries are expected to create numerous opportunities for the market players.
Trends: Acquisitions by leading companies in the market
Leading companies in the wound care market have been making strategic acquisitions to expand their product portfolio and strengthen their position in the market. For instance, Smith & Nephew plc acquired Osiris Therapeutics, Inc. in 2019 for $660 million. Through this acquisition, Smith & Nephew gained access to Osiris’ portfolio of tissue regeneration products, which included products for wound care and sports medicine. Similarly, ConvaTec Group PLC acquired Acelity in 2019 for $6.7 billion to strengthen its position in the wound care market. Through this acquisition, ConvaTec gained access to Acelity’s portfolio of advanced wound care products, which included products such as wound dressings, negative pressure wound therapy systems, and skin substitutes.
Restraints: Increased cost of wound care products
The increased cost of wound care products is a major restraint to the growth of the wound care market. This is because the cost of wound care products such as dressings, bandages, antiseptics, and other products is rising due to increasing raw material costs and labor costs. Additionally, the lack of reimbursement for wound care products and treatments is also a major restraint to the market. This is because most of the wound care treatments are not covered by insurance and thus, the cost of the treatments have to be borne by the patients. This makes it difficult for many people to afford wound care treatments, which in turn affects the market growth.
The advanced wound care products segment dominated the wound care market.
An increased incidence of burn injuries and an increased number of surgical procedures have significantly increased the use of advanced wound care products. Faster relief and better treatment lead to increased use of advanced wound care products.
The surgical and traumatic wounds segment accounted for the largest share of the wound care market.
Significant numbers of road accidents and the resulting increase in injuries pose a serious health concern worldwide. Severe and traumatic injuries from such accidents have ensured the demand for wound care products.
The hospitals and clinics segment has the largest share in the wound care market.
The high patient inflow in hospitals and clinics for chronic wounds and surgical wounds Increasing incidences of obesity and diabetes are leading to a delay in wound healing. With the increase in the obesity rate, the number of wounds, infections, and critical illnesses or surgeries is expected to rise, thus driving demand for hospitals and clinics.
Asia Pacific is expected to be the fastest-growing region for the wound care market.
Increasing healthcare spending, growing per capita income, rising demand for cutting-edge technologies, and the expansion of private-sector hospitals to rural areas are all occurring in various APAC countries. The low labour costs and the favourable regulatory environment in this region are also expected to propel market growth.
To know about the assumptions considered for the study, download the pdf brochure
Some of the prominent players in the wound care market (2022–2027)
- 3M Company (US)
- Smith & Nephew PLC (UK)
- Cardinal Health (US)
- Medtronic PLC (Ireland)
- B. Braun Melsungen AG (Germany)
Wound Care Market Report Scope:
|
Report Metric |
Details |
|
Market Revenue in 2022 |
$20.8 billion |
|
Estimated Value by 2027 |
$27.2 billion |
|
Growth Rate |
Poised to grow at a CAGR of 5.4% |
|
Market Segmentation |
By Product, wound type, end user, and region |
|
Market Driver |
rising incidence of diabetes that affects wound healing |
|
Market Opportunity |
emerging countries |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
This research report categorizes the wound care market into following segments & sub-segments:
By Product
- Advanced Wound Care Products
- Surgical Wound Care Products
- Traditional Wound Care Products
By Wound Type
- surgical & traumatic wounds
- Diabetic foot ulcers
- Pressure ulcers
- Venous leg ulcers
- Burns & other wounds
By End User
- Hospitals and Clinics
- Long-term patient care
- Home care settings
- Other end users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Recent Developments
- Advanced Medical Solutions Group PLC and Mölnlycke Health Care AB: In March 2021, Advanced Medical Solutions Group PLC (AMS) announced its acquisition of Mölnlycke Health Care AB, a global provider of advanced wound care and surgical products. The deal is worth £1.14 billion and is expected to complete in the first half of 2021.
- Medline Industries Inc. and Salk Inc.: In July 2022 Medline Industries Inc. acquired Salk Inc., a leading manufacturer of high-quality wound care products. The acquisition is expected to strengthen Medline’s portfolio of wound care products and expand its distribution channels.
- Smith & Nephew and Osiris Therapeutics, Inc.: In December 2022, Smith & Nephew acquired Osiris Therapeutics, Inc., a leading biotechnology company specializing in regenerative medicine products for wound care. The acquisition is valued at $660 million and will expand Smith & Nephew’s presence in the wound care market.
- B. Braun Medical Inc. and Epitech Group: In March 2023, B. Braun Medical Inc. announced its acquisition of the Epitech Group, a leading provider of wound care products. The deal is expected to strengthen B. Braun’s presence in the wound care market and expand its portfolio of products.
- Acelity L.P. Inc. and Systagenix Wound Management Ltd.: In April 2023, Acelity L.P. Inc. announced its acquisition of Systagenix Wound Management Ltd., a leading provider of advanced wound care products. The deal is valued at $485 million and is expected to expand Acelity’s portfolio of wound care products.
Frequently Asked Questions (FAQs):
What is the projected market value of the global wound care market?
The global market of wound care is projected to reach USD 27.2 billion.
What is the estimated growth rate (CAGR) of the global wound care market for the next five years?
The global wound care market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.4% from 2023 to 2027.
What are the major revenue pockets in the wound care market currently?
Increasing healthcare spending, growing per capita income, rising demand for cutting-edge technologies, the expansion of private-sector hospitals to rural areas in various APAC countries. The low labor costs and the favorable regulatory environment in this region are also expected to propel market growth.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 35)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY
1.3 MARKETS COVERED
1.3.1 WOUND CARE MARKET
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 40)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 1 WOUND CARE MARKET: RESEARCH DESIGN METHODOLOGY
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Primary sources
2.2.2.2 Key data from primary sources
2.2.2.3 Key industry insights
2.2.2.4 Breakdown of primary interviews
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 Approach 3: Presentations of companies and primary interviews
2.3.1.3 Growth forecast
2.3.1.4 CAGR projections
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 6 GLOBAL MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS
2.8 GROWTH RATE ASSUMPTIONS
2.9 RISK ASSESSMENT
2.9.1 RISK ASSESSMENT: GLOBAL MARKET
3 EXECUTIVE SUMMARY (Page No. - 52)
FIGURE 8 WOUND CARE MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 9 MARKET, BY WOUND TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 10 MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 11 MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 55)
4.1 WOUND CARE MARKET OVERVIEW
FIGURE 12 GROWING PREVALENCE OF DISEASES & HEALTH CONDITIONS THAT AFFECT WOUND HEALING CAPABILITIES TO DRIVE THE MARKET GROWTH
4.2 MARKET SHARE, BY PRODUCT, 2022 VS. 2027
FIGURE 13 THE ADVANCED WOUND CARE PRODUCTS SEGMENT IS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.3 MARKET SHARE, BY WOUND TYPE, 2022 VS. 2027
FIGURE 14 SURGICAL & TRAUMATIC SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.4 MARKET SHARE, BY END USER, 2022 VS. 2027
FIGURE 15 THE HOSPITALS AND CLINICS SEGMENT IS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 THE ASIA PACIFIC REGION IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 58)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of diseases & health conditions that affect wound healing capabilities
5.2.1.1.1 Growing geriatric population
5.2.1.1.2 Rising prevalence of diabetes
FIGURE 18 INCIDENCE OF DIABETES, BY REGION, 2019 VS. 2045 (MILLION CASES)
5.2.1.1.3 Increasing number of surgical procedures worldwide
TABLE 1 PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED IN THE US
5.2.2 RISING EXPENDITURE ON CHRONIC WOUNDS
5.2.3 INCREASING INCIDENCE OF BURN INJURIES
5.2.4 RISING CASES OF TRAUMATIC INJURIES
TABLE 2 PREVALENCE OF ROAD ACCIDENTS
5.2.5 TECHNOLOGICAL ADVANCEMENTS IN WOUND CARE PRODUCTS
5.2.6 RISING USE OF REGENERATIVE MEDICINE FOR WOUND MANAGEMENT
5.2.7 RESTRAINTS
5.2.7.1 High costs of advanced wound care products
TABLE 3 AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS
5.2.7.2 Risks associated with the use of advanced wound care products
TABLE 4 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS
5.2.8 OPPORTUNITIES
5.2.8.1 Growth potential of emerging countries
TABLE 5 STRATEGIC DEVELOPMENTS IN THE ASIA PACIFIC REGION
5.2.9 TRENDS
5.2.9.1 Acquisitions by leading companies in the market
5.2.9.1.1 Rising focus on expanding current technologies and launching novel products
5.2.9.1.2 Smart wound dressings for minimum invasiveness
5.2.9.1.3 Crab shell bandages
5.2.9.1.4 Color-changing dressings
5.2.9.1.5 Integration of nanotechnology in advanced wound care products
5.2.9.1.6 Novel wound assessment & measurement devices
5.3 IMPACT OF COVID-19 ON THE GLOBAL MARKET
5.4 PRICING ANALYSIS
TABLE 6 AVERAGE SELLING PRICE OF WOUND CARE PRODUCTS (2022)
5.5 PATENT ANALYSIS
FIGURE 19 PATENT ANALYSIS OF THE MARKET
5.5.1 LIST OF MAJOR PATENTS
5.6 VALUE CHAIN ANALYSIS
FIGURE 20 VALUE CHAIN ANALYSIS OF THE GLOBAL MARKET: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 21 MARKET: SUPPLY CHAIN ANALYSIS
5.8 ECOSYSTEM/MARKET MAP
FIGURE 22 MARKET: ECOSYSTEM/MARKET MAP
5.8.1 MARKET: ECOSYSTEM ROLE
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT FROM NEW ENTRANTS
5.9.2 THREAT FROM SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 DEGREE OF COMPETITION
5.10 REGULATORY LANDSCAPE
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.1 NORTH AMERICA
5.10.1.1 US
5.10.1.2 Canada
5.10.2 EUROPE
5.10.3 ASIA PACIFIC
5.10.3.1 China
5.10.3.2 Japan
5.10.3.3 India
5.10.4 LATIN AMERICA
5.10.4.1 Brazil
5.10.4.2 Mexico
5.10.5 MIDDLE EAST
5.10.6 AFRICA
5.11 TRADE ANALYSIS
5.11.1 TRADE ANALYSIS FOR ADHESIVE DRESSINGS
5.11.1.1 Import data for adhesive dressings by country, 2017–2021 (USD million)
5.11.1.2 Export data for adhesive dressings by country, 2017–2021 (USD million)
5.12 TECHNOLOGY ANALYSIS
5.13 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 12 GLOBAL MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.14.1 REVENUE SOURCES ARE SHIFTING TOWARDS TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC
5.14.2 REVENUE SHIFT IN THE MARKET
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
FIGURE 23 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF WOUND CARE PRODUCTS
TABLE 13 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF WOUND CARE PRODUCTS (%)
5.15.2 BUYING CRITERIA
FIGURE 24 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS
TABLE 14 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS
5.16 CASE STUDIES
5.16.1 CASE STUDY: TIELLE ESSENTIAL SILICONE FOAM DRESSINGS USED IN A NON-HEALING DIABETIC FOOT ULCER ON THE RIGHT FOOT
6 WOUND CARE MARKET, BY PRODUCT (Page No. - 88)
6.1 INTRODUCTION
TABLE 15 MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.1.1 PRIMARY NOTES
6.1.1.1 Key industry insights
6.2 ADVANCED WOUND CARE PRODUCTS
TABLE 16 ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 17 ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2.1 ADVANCED WOUND CARE DRESSINGS
TABLE 18 ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 19 ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2.1.1 Foam dressings
TABLE 20 KEY PRODUCTS IN THE FOAM DRESSINGS MARKET
TABLE 21 FOAM DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 22 FOAM DRESSINGS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2.1.1.1 Silicone dressings
6.2.1.1.1.1 Silicone dressings help expedite wound closure and reduce the risk of maceration – a key factor driving the market growth
TABLE 23 SILICONE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.1.2 Non-silicone dressings
6.2.1.1.2.1 Non-silicone dressings are effective in scar removal and wound healing
TABLE 24 NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.2 Hydrocolloid dressings
6.2.1.2.1 Hydrocolloid dressings are cost-effective and promote a moist environment which is required for optimal healing
TABLE 25 KEY PRODUCTS IN THE HYDROCOLLOID DRESSINGS MARKET
TABLE 26 HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.3 Film dressings
6.2.1.3.1 The non-absorbable nature of film dressings ensures strong adoption
TABLE 27 FILM DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.4 Alginate dressings
6.2.1.4.1 Alginate dressings are well suited for diabetic & foot ulcers
TABLE 28 ALGINATE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.5 Hydrogel dressings
6.2.1.5.1 Hydrogel dressings are available in several forms for effective use
TABLE 29 HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.6 Collagen dressings
6.2.1.6.1 A favorable reimbursement scenario for collagen dressings to support the market growth
TABLE 30 COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.7 Hydrofiber dressings
6.2.1.7.1 Hydrofiber dressings combine the properties of hydrocolloids and collagen
TABLE 31 HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.8 Wound contact layers
6.2.1.8.1 Wound contact layers protect wound beds from bacterial & fungal growth
TABLE 32 WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.9 Superabsorbent dressings
6.2.1.9.1 Superabsorbent dressings are designed for highly exuding wounds
TABLE 33 SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.10 Other advanced wound care dressings
TABLE 34 OTHER ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 36 NON-ANTIMICROBIAL DRESSINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 37 ANTIMICROBIAL DRESSINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.2 WOUND THERAPY DEVICES
TABLE 38 WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 39 WOUND THERAPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2.2.1 Portable & conventional negative pressure wound therapy devices (NPWT)
6.2.2.1.1 Growing adoption of single-use NPWT devices in homecare to drive the market growth
TABLE 40 PORTABLE & CONVENTIONAL NPWT DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.2 Debridement devices & accessories
6.2.2.2.1 Development of novel technologies to support the growth of this segment
TABLE 41 DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.3 Wound assessment & monitoring devices
6.2.2.3.1 Potential cost-reducing capabilities of wound assessment & monitoring devices to boost its adoption
TABLE 42 WOUND ASSESSMENT & MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 OTHER DEVICES & ACCESSORIES
TABLE 43 OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.4 GRAFTS & MATRICES
6.2.4.1 Grafts & matrices promote healing & wound closure
TABLE 44 KEY PRODUCTS IN THE GRAFTS & MATRICES MARKET
TABLE 45 GRAFTS & MATRICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.5 TOPICAL AGENTS
6.2.5.1 Cost-effectiveness & ease-of-use in home care settings to drive the growth of this segment
TABLE 46 TOPICAL AGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 SURGICAL WOUND CARE PRODUCTS
TABLE 47 SURGICAL CARE PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 48 SURGICAL CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.3.1 SUTURES
6.3.1.1 Increasing number of surgical procedures and the high tensile strength afforded by sutures drive the market growth
TABLE 49 SUTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.2 STAPLERS
6.3.2.1 Staplers are considered to be more accurate than suturing and less likely to allow leakage; a key factor driving adoption
TABLE 50 STAPLERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3 TISSUE ADHESIVES, SEALANTS, AND GLUES
TABLE 51 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 52 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.3.1 Fibrin-based sealants
6.3.3.1.1 Fibrin-based sealants provide better results than sutures, thus driving the product demand
TABLE 53 FIBRIN-BASED SEALANTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3.2 Collagen-based sealants
6.3.3.2.1 Collagen-based sealants are used in surgical procedures as an adjunctive to hemostatic agents
TABLE 54 COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3.3 Synthetic adhesives
6.3.3.3.1 Synthetic adhesives have additional sealing properties than traditional staples; a key factor driving the segment growth
TABLE 55 SYNTHETIC ADHESIVES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 TRADITIONAL WOUND CARE PRODUCTS
TABLE 56 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 57 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.4.1 MEDICAL TAPES
6.4.1.1 Latex-free tapes are gentle to the skin and hypoallergenic for sensitive patients
TABLE 58 MEDICAL TAPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4.2 DRESSINGS
6.4.2.1 Presence of a large patient population for pressure ulcers has ensured a sustained demand for these products
TABLE 59 DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4.3 CLEANSING AGENTS
6.4.3.1 High risk of HAIs from open wounds to drive the market growth
TABLE 60 TYPES OF CLEANSING AGENTS
TABLE 61 CLEANSING AGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 WOUND CARE MARKET, BY WOUND TYPE (Page No. - 136)
7.1 INTRODUCTION
TABLE 62 MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
7.2 SURGICAL & TRAUMATIC WOUNDS
7.2.1 THE RISING VOLUME OF SURGICAL PROCEDURES DRIVES THE GROWTH OF THIS SEGMENT
TABLE 63 MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 DIABETIC FOOT ULCERS
7.3.1 INCREASING PREVALENCE OF DIABETES TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 64 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN 2021 (20-79 AGE GROUP)
TABLE 65 Global Market FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 PRESSURE ULCERS
7.4.1 GROWING GERIATRIC POPULATION TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 66 Global Market FOR PRESSURE ULCERS, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 VENOUS LEG ULCERS
7.5.1 RISING PREVALENCE OF OBESITY TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 67 MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 BURNS AND OTHER WOUNDS
7.6.1 HIGH INCIDENCE OF BURN INJURIES TO DRIVE THE MARKET GROWTH
TABLE 68 MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY, 2020–2027 (USD MILLION)
8 WOUND CARE MARKET, BY END USER (Page No. - 146)
8.1 INTRODUCTION
TABLE 69 MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS AND CLINICS
TABLE 70 TOTAL NUMBER OF HOSPITALS, BY COUNTRY (IN 2019)
TABLE 71 Global Market FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 72 Global Market FOR HOSPITALS AND CLINICS, BY TYPE, 2020–2027 (USD MILLION)
8.2.1 INPATIENT SETTINGS
8.2.1.1 Increasing hospital admissions due to HAIs to drive the growth of this segment
TABLE 73 MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.2 OUTPATIENT SETTINGS
8.2.2.1 Rising costs of inpatient facilities drive the demand for outpatient care settings
TABLE 74 Global Market FOR OUTPATIENT SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 HOME CARE SETTINGS
8.3.1 LOW COSTS AND CONVENIENCE TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
TABLE 75 MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 LONG-TERM CARE FACILITIES
8.4.1 GROWTH IN THE GERIATRIC & VULNERABLE POPULATIONS DRIVES THE DEMAND FOR BETTER LONG-TERM CARE
TABLE 76 MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 OTHER END USERS
TABLE 77 MARKET FOR OTHER END-USERS, BY COUNTRY, 2020–2027 (USD MILLION)
9 WOUND CARE MARKET, BY REGION (Page No. - 156)
9.1 INTRODUCTIONS
TABLE 78 MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 25 NORTH AMERICA: Wound Care Market SNAPSHOT
TABLE 79 NORTH AMERICA: Wound Care Market , BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 NORTH AMERICA: Wound Care Market , BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 81 NORTH AMERICA: Wound Care Market , BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 82 NORTH AMERICA: Wound Care Market , BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 83 NORTH AMERICA: Wound Care Market , BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 84 NORTH AMERICA: Wound Care Market , BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 85 NORTH AMERICA: Wound Care Market , BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 86 NORTH AMERICA: Wound Care Market ; BY TISSUES ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 87 NORTH AMERICA: MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 88 NORTH AMERICA: MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 89 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Rising incidence of chronic diseases and diabetes to drive the market growth
TABLE 90 US: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 91 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 High prevalence of HAIs drives the market growth for wound care management in Canada
TABLE 92 INCIDENCE OF DIABETES IN CANADA, 2019 VS. 2029
TABLE 93 CANADA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 94 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 95 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP)
TABLE 96 PREVALENCE OF DIABETES IN EUROPE, 2019 VS. 2045
TABLE 97 EUROPE: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 98 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 99 EUROPE: MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 100 EUROPE: MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 101 EUROPE: MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 102 EUROPE: MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 103 EUROPE: MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 104 EUROPE: MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 105 EUROPE: MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 106 EUROPE: MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 107 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 The large diabetic population in Germany has supported product development & commercialization for the wound care market
TABLE 108 GERMANY: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 109 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 The rising senior population drives the market growth in France
TABLE 110 FRANCE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 111 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 UK
9.3.3.1 Rising incidence of chronic wounds to propel market growth in the UK
TABLE 112 UK: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 113 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Growth in this market is driven by improving quality & accessibility to medical care and products
TABLE 114 ITALY: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 115 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing life expectancies and the growing geriatric population to ensure the market growth in Spain
TABLE 116 SPAIN: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 117 SPAIN: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 RUSSIA
9.3.6.1 Government focus on increasing diabetes awareness to favor the market growth
TABLE 118 RUSSIA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 119 RUSSIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 120 ROE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 121 ROE: MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 122 ROE: MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 123 ROE: MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 124 ROE: MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 125 ROE: MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 126 ROE: MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 127 ROE: MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 128 ROE: MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 129 ROE: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 26 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 130 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 131 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 132 ASIA PACIFIC: MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 133 ASIA PACIFIC: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 134 ASIA PACIFIC: MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 135 ASIA PACIFIC: MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 136 ASIA PACIFIC: MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 137 ASIA PACIFIC: MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 138 ASIA PACIFIC: MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 139 ASIA PACIFIC: MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 140 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Increasing incidence of DFUs to support the market growth in China
TABLE 141 CHINA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 142 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Implementations of regulations in Japan have resulted in a favorable environment for wound care devices
TABLE 143 JAPAN: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 144 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing medical tourism in India to support the market growth for wound care management
TABLE 145 INDIA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 146 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Increasing initiatives to spread awareness on effective wound care to support the market growth
TABLE 147 AUSTRALIA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 148 AUSTRALIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Local manufacturers in South Korea are partnering with research organizations for advanced wound care products; a key growth driver
TABLE 149 SOUTH KOREA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 150 SOUTH KOREA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.6 SINGAPORE
9.4.6.1 The growing prevalence of diabetes drives the market growth in Singapore
TABLE 151 SINGAPORE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 152 SINGAPORE: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 153 ROAPAC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 154 ROAPAC: MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 155 ROAPAC: MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 156 ROAPAC: MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 157 ROAPAC: MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 158 ROAPAC: MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 159 ROAPAC: MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 160 ROAPAC: MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 161 ROAPAC: MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 162 ROAPAC: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
TABLE 163 LATIN AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 164 LATIN AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 165 LATIN AMERICA: MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 166 LATIN AMERICA: MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 167 LATIN AMERICA: MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 168 LATIN AMERICA: MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 169 LATIN AMERICA: MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 170 LATIN AMERICA: MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 171 LATIN AMERICA: MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 172 LATIN AMERICA: MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 173 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil is the largest healthcare market in Latin America
TABLE 174 BRAZIL: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 175 BRAZIL: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Diabetes is the second-highest cause of mortality in Mexico
TABLE 176 MEXICO: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 177 MEXICO: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 178 ROLATAM: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 179 ROLATAM: MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 180 ROLATAM: MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 181 ROLATAM: MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 182 ROLATAM: MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 183 ROLATAM: MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 184 ROLATAM: MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 185 ROLATAM: MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 186 ROLATAM: MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 187 ROLATAM: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 RISING PREVALENCE OF DIABETES IN THE REGION TO SUPPORT THE MARKET GROWTH
TABLE 188 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 189 MIDDLE EAST & AFRICA: MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 190 MIDDLE EAST & AFRICA: MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 191 MIDDLE EAST & AFRICA: MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 192 MIDDLE EAST & AFRICA: MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 193 MIDDLE EAST & AFRICA: MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 194 MIDDLE EAST & AFRICA: MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 195 MIDDLE EAST & AFRICA: MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 197 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 219)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE WOUND CARE MARKET
TABLE 198 OVERVIEW OF STRATEGIES DEPLOYED BY KEY WOUND CARE MANUFACTURING COMPANIES
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 27 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE WOUND CARE MARKET
10.4 MARKET SHARE ANALYSIS
10.4.1 WOUND CARE MARKET
FIGURE 28 WOUND CARE MARKET SHARE BY KEY PLAYER (2021)
TABLE 199 WOUND CARE MARKET: DEGREE OF COMPETITION
10.4.1.1 Advanced wound care
FIGURE 29 GLOBAL WOUND CARE MARKET SHARE FOR ADVANCED WOUND CARE BY KEY PLAYERS (2021)
10.4.1.2 Negative pressure wound therapy (NPWT)
FIGURE 30 GLOBAL WOUND CARE MARKET SHARE FOR NPWT BY KEY PLAYER (2021)
10.4.1.3 Advanced wound dressings
FIGURE 31 GLOBAL WOUND CARE MARKET RANKING FOR ADVANCED WOUND DRESSINGS, BY KEY PLAYER, 2021
10.4.1.4 Surgical sutures
FIGURE 32 GLOBAL WOUND CARE MARKET RANKING FOR SURGICAL SUTURES, BY KEY PLAYER, 2021
10.4.1.5 Debridement devices
FIGURE 33 GLOBAL WOUND CARE MARKET RANKING FOR DEBRIDEMENT DEVICES, BY KEY PLAYER, 2021
10.4.1.6 Traditional and surgical wound care product markets
TABLE 200 GLOBAL WOUND CARE MARKET RANKING FOR TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS, BY KEY PLAYER, 2021
10.5 COMPANY EVALUATION QUADRANT
10.5.1 LIST OF EVALUATED VENDORS
10.5.2 STARS
10.5.3 EMERGING LEADERS
10.5.4 PERVASIVE PLAYERS
10.5.5 PARTICIPANTS
FIGURE 34 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 35 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
10.7 COMPETITIVE BENCHMARKING
10.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
FIGURE 36 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE WOUND CARE MARKET
TABLE 201 WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 202 COMPANY PRODUCT & SERVICE FOOTPRINT
TABLE 203 COMPANY REGIONAL FOOTPRINT
TABLE 204 WOUND CARE MARKET: DETAILED LIST OF KEY START-UPS/SMES
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 205 KEY PRODUCT LAUNCHES &
10.8.2 DEALS
TABLE 206 KEY DEALS
11 COMPANY PROFILES (Page No. - 234)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 3M COMPANY
TABLE 207 3M COMPANY: BUSINESS OVERVIEW
FIGURE 37 3M COMPANY: BUSSINESS OVERVIEW (2021)
11.1.2 CARDINAL HEALTH
TABLE 208 CARDINAL HEALTH.: BUSINESS OVERVIEW
FIGURE 38 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
11.1.3 MEDTRONIC PLC
TABLE 209 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 39 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
11.1.4 B. BRAUN MELSUNGEN AG
TABLE 210 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
FIGURE 40 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2021)
11.1.5 SMITH & NEPHEW PLC
TABLE 211 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 41 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)
11.1.6 MÖLNLYCKE HEALTH CARE AB
TABLE 212 MÖLNLYCKE HEALTH CARE AB: BUSINESS OVERVIEW
FIGURE 42 MÖLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT (2021)
11.1.7 PAUL HARTMANN AG
TABLE 213 PAUL HARTMANN AG: BUSINESS OVERVIEW
FIGURE 43 PAUL HARTMANN AG: COMPANY SNAPSHOT (2021)
11.1.8 CONVATEC GROUP
TABLE 214 CONVATEC GROUP: BUSINESS OVERVIEW
FIGURE 44 CONVATEC GROUP: COMPANY SNAPSHOT (2021)
11.1.9 ZIMMER BIOMET HOLDINGS INC.
TABLE 215 ZIMMER BIOMET HOLDINGS INC.: BUSINESS OVERVIEW
FIGURE 45 ZIMMER BIOMET HOLDINGS INC.: COMPANY SNAPSHOT (2021)
11.1.10 BAXTER INTERNATIONAL, INC.
TABLE 216 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW
FIGURE 46 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2021)
11.1.11 ORGANOGENESIS HOLDINGS INC.
TABLE 217 ORGANOGENESIS HOLDINGS INC.: BUSINESS OVERVIEW
FIGURE 47 ORGANOGENESIS HOLDINGS INC.: COMPANY SNAPSHOT (2021)
11.1.12 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 218 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 48 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2021)
11.1.13 COLOPLAST A/S
TABLE 219 COLOPLAST A/S: BUSINESS OVERVIEW
FIGURE 49 COLOPLAST A/S: COMPANY SNAPSHOT (2021)
11.1.14 MIMEDX GROUP, INC.
TABLE 220 MIMEDX GROUP, INC.: BUSINESS OVERVIEW
FIGURE 50 MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2021)
11.1.15 BIOVENTUS
TABLE 221 BIOVENTUS: BUSINESS OVERVIEW
FIGURE 51 BIOVENTUS: COMPANY SNAPSHOT (2021)
11.2 OTHER PLAYERS
11.2.1 ETHICON, INC.
TABLE 222 ETHICON, INC.: COMPANY OVERVIEW
11.2.2 DEROYAL INDUSTRIES
TABLE 223 DEROYAL INDUSTRIES: COMPANY OVERVIEW
11.2.3 KERECIS
TABLE 224 KERECIS: COMPANY OVERVIEW
11.2.4 ACELL
TABLE 225 ACELL: COMPANY OVERVIEW
11.2.5 LOHMANN & RAUSCHER GMBH & CO KG.
TABLE 226 LOHMANN & RAUSCHER GMBH & CO KG.: COMPANY OVERVIEW
11.2.6 MEDELA AG
TABLE 227 MEDELA AG: COMPANY OVERVIEW
11.2.7 TALLEY GROUP
TABLE 228 TALLEY GROUP: COMPANY OVERVIEW
11.2.8 WELCARE INDUSTRIES SPA
TABLE 229 ELCARE INDUSTRIES SPA: COMPANY OVERVIEW
11.2.9 WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.
TABLE 230 WUHAN VSD SCIENCE & TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
11.2.10 PENSAR MEDICAL
TABLE 231 PENSAR MEDICAL: COMPANY OVERVIEW
11.2.11 HAROMED BV
TABLE 232 HAROMED BV: COMPANY OVERVIEW
11.2.12 DERMARITE INDUSTRIES LLC
TABLE 233 DERMARITE INDUSTRIES LLC: COMPANY OVERVIEW
11.2.13 MEDLINE INDUSTRIS, INC.
TABLE 234 MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW
11.2.14 ADVANCIS MEDICAL LLC
TABLE 235 ADVANCIS MEDICAL LLC: COMPANY OVERVIEW
11.2.15 MIL LABORATORIES PVT. LTD.
TABLE 236 MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 309)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the wound care market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the wound care market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the wound care market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Top-Down Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, segment, and forecast the wound market by product, wound type, end user and region.
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and trends).
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market.
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa,
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2.
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, collaborations, agreements, expansion, contract and other developments in the wound care market.
- To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy.
Available Customisations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Country Information
Wound Care market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa.
Company profiles
- Product portfolio matrix for leading market players.
Growth opportunities and latent adjacency in Wound Care Market
We want in-depth details of Wound Care Market Size, Growth, Forecast Research Report [2029 - 2030]
Which is the fastest growing market of Wound Care Market?
Can you enlighten us with your market intelligence to grow and sustain in Wound Care Market?